Valinor: $13 Million Seed Funding Raised To Boost Clinical Trial Success With Multimodal Machine Learning
By Amit Chowdhry ● Dec 17, 2025
Valinor, a San Francisco-based AI company focused on improving clinical trial outcomes through machine-learning-driven patient response prediction, announced $13 million in seed funding to scale its multimodal platform for patient selection. The round was led by CRV, Harpoon Ventures, Amino Collective, and Pelion Venture Partners, with additional participation from angel investors and operators, including Charlie Songhurst, Surya Midha, Axel Ericsson, and Kyle Harrison.